NCT01416493View on ClinicalTrials.gov

Bovine Intestinal Alkaline Phosphatase (bIAP) Modulating Rheumatoid Arthritis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Acute Rheumatoid Arthritis
Interventions
DRUG

s.c. injections of bovine intestinal Alkaline Phosphatase

daily subcutaneous treatment with two injections of 2000IU bIAP for three days

Trial Locations (1)

ME16 9QQ

Maidstone Hospital, Dept. Rheumatology, Maidstone

Sponsors

Collaborators (1)

Aix Scientifics
All Listed Sponsors
collaborator

Aix Scientifics

INDUSTRY

lead

Alloksys Life Sciences B.V.

INDUSTRY